Facility

UTAK LABORATORIES, INC.

1 recall(s) on record — most severe on record: Class III.

Key facts

1recalls · worst Class III

—inspections in our data

—warning letters in our data

Recalls are listed for the parent company: openFDA recall records do not name a facility. How we attribute records

FDA Establishment Identifier (FEI)	2022375
Establishment type	Manufacture Medical Device
Location	25020 AVENUE TIBBITTS VALENCIA, CA, US 91355
Registration status	Active · expires 2026
Parent company	UTAK LABORATORIES, I (owner-operator 2022375)
Brand names	Amoxapine Control

Activity by year

Recalls (1)

Devices registered here (1)

Drug Mixture Control Materials
Product code DIF (opens in a new tab) · Class I · Clinical Toxicology · 21 CFR 862.3280

Recalls & enforcement

Class IIITerminated2020-03-20
The product has an incorrect reference value for cadmium and an incorrect expected range.

All facilities operated by UTAK LABORATORIES, I

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)

Cite this record

RegWarden. “UTAK LABORATORIES, INC. (FEI 2022375) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/2022375-utak-laboratories-inc/

Not open yet

Alerts for UTAK LABORATORIES, INC.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.